If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmati Aim Vct Regulatory News (AMAT)

  • There is currently no data for AMAT

Strategic Review

14 Mar 2024 07:00

RNS Number : 7782G
Amati AIM VCT PLC
14 March 2024
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICITON WHERE TO DO SO WOULD COSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THE JURISDICITON.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATON FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. ON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

For immediate release

14 March 2024

Amati AIM VCT plc

 

Strategic review

 

The Board of Amati AIM VCT plc (the "Company") confirms that it has, in conjunction with the Company's investment manager, Amati Global Investors Limited (the "Investment Manager"), been considering the Company's strategic options in the light of ongoing challenges in the AIM market and the resultant performance issues faced by the Company. As part of this review, the Board intends to consider whether the Company's investment strategy should be expanded to facilitate investment in a broader range of securities while continuing to comply with the rules applicable to VCTs. 

 

The Board also notes the recent announcement of a recommended offer (the "Offer") for Mattioli Woods plc by Tiger Bidco Limited (owned by funds managed by Pollen Street Capital Limited). Mattioli Woods plc currently owns 49% of the issued share capital of the Investment Manager. The ongoing review of strategic options will take into account any possible impact of the Offer on the Company and the management of its investment portfolio.

 

Further details of the strategic review will be included in the Company's annual report and accounts which are expected to be published shortly.

 

Enquiries:

 

Fiona Wollocombe, Chair

Amati AIM VCT plc

Email: info@amatiglobal.com

 

Douglas Armstrong

Dickson Minto Advisers

Financial Adviser to the Company

Telephone: 020 7649 6823

 

Important Information

This announcement is released by the Company and the information contained within this announcement is deemed by the Company to constitute inside information for the purposes of Article 7 of the UK version of the EU Market Abuse Regulation (Regulation (EU) No.596/2014) which forms part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended. Upon the publication of this announcement via a Regulatory Information Service, such information is now considered to be in the public domain.

Legal Entity Identifier (LEI): 213800HAEDBBK9RWCD25

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDSFMFUDELSEID
Date   Source Headline
4th Apr 20194:26 pmRNSTransaction in Own Shares
2nd Apr 20192:20 pmRNSTransaction in Own Shares
2nd Apr 201911:54 amRNSNet Asset Value(s)
1st Apr 20198:47 amRNSTotal Voting Rights
25th Mar 20192:54 pmRNSTransaction in Own Shares
22nd Mar 20195:00 pmRNSNet Asset Value(s)
21st Mar 201912:33 pmRNSTransaction in Own Shares
18th Mar 20194:47 pmRNSNet Asset Value(s)
11th Mar 20191:07 pmRNSNet Asset Value(s)
7th Mar 201911:36 amRNSHolding(s) in Company
4th Mar 20193:29 pmRNSIssue of Equity
1st Mar 20193:56 pmRNSNet Asset Value(s)
1st Mar 20198:43 amRNSTotal Voting Rights
25th Feb 20192:40 pmRNSNet Asset Value(s)
20th Feb 20192:04 pmRNSDirector/PDMR Shareholding
20th Feb 20192:03 pmRNSIssue of Equity
18th Feb 201911:08 amRNSNet Asset Value(s)
15th Feb 201911:03 amRNSTransaction in Own Shares
8th Feb 20194:48 pmRNSNet Asset Value(s)
8th Feb 20191:09 pmRNSTransaction in Own Shares
4th Feb 201911:33 amRNSNet Asset Value(s)
1st Feb 20198:58 amRNSTotal Voting Rights
1st Feb 20197:00 amRNSOffer for subscription
28th Jan 20191:31 pmRNSNet Asset Value(s)
21st Jan 201912:11 pmRNSNet Asset Value(s)
21st Jan 201910:55 amRNSHolding(s) in Company
18th Jan 20194:23 pmRNSTransaction in Own Shares
11th Jan 20195:22 pmRNSNet Asset Value(s)
3rd Jan 201912:44 pmRNSNet Asset Value(s)
3rd Jan 20199:48 amRNSTotal Voting Rights
3rd Jan 20197:00 amRNSHolding(s) in Company
21st Dec 201811:37 amRNSIntention to Launch an Offer for Subscription
20th Dec 20185:04 pmRNSHolding(s) in Company
20th Dec 20184:28 pmRNSNet Asset Value(s)
20th Dec 20183:56 pmRNSTransaction in Own Shares
18th Dec 20183:35 pmRNSTransaction in Own Shares
17th Dec 20183:47 pmRNSHolding(s) in Company
17th Dec 20182:33 pmRNSNet Asset Value(s)
7th Dec 20184:59 pmRNSNet Asset Value(s)
6th Dec 20182:42 pmRNSTransaction in Own Shares
6th Dec 201812:15 pmRNSHolding(s) in Company
5th Dec 20182:04 pmRNSTransaction in Own Shares
4th Dec 20182:37 pmRNSNet Asset Value(s)
3rd Dec 20188:14 amRNSTotal Voting Rights
26th Nov 201811:57 amRNSDirector/PDMR Shareholding
26th Nov 20188:14 amRNSIssue of Equity
23rd Nov 20181:20 pmRNSNet Asset Value(s)
20th Nov 20187:00 amRNSTR-1: notification of major holdings
19th Nov 20189:42 amRNSNet Asset Value(s)
12th Nov 20184:08 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.